Polyradiculoneuropathy induced by immune checkpoint inhibitors: a case series and review of the literature
Polyradiculoneuropathy induced by immune checkpoint inhibitors: a case series and review of the literature
复制标题
免疫检查点抑制剂诱发的多发性神经根神经病:病例系列及文献综述
DOI:
10.1007/s00415-020-10213-x
复制
发表时间:
2020
影响因子:
6
通讯作者:
Suzuki Shigeaki
中科院分区:
文献类型:
--
作者:
Okada Kensuke;Seki Morinobu;Yaguchi Hiroshi;Sakuta Kenichi;Mukai Taiji;Yamada Satoshi;Oki Koichi;Nakahara Jin;Suzuki Shigeaki
ObjectiveThe purpose of the present study is to report the clinical characteristics of polyradiculoneuropathy induced by immune checkpoint inhibitors (ICIs).MethodsWe retrospectively reviewed lists of all inpatients with neurological immune-related adverse events (irAEs) treated at the neurology departments of three hospitals in January 2017 and December 2019. We also performed a review of the previous case reports with polyradiculoneuropathy induced by ICI therapy.ResultsWe had 4 patients with polyradiculoneuropathy following ICI therapy. We comprehensively reviewed our 4 patients and 32 previous case reports. There were 28 men and 8 women with a mean onset age of 61 years. ICI monotherapy was performed in 27 patients, whereas the combination of ICIs was administered in 9 patients. All patients except 2 showed limb weakness, which was observed symmetrically and predominantly in the legs rather than the arms. Bulbar involvement was observed in 7 patients. The laboratory findings were demyelination in electrophysiological studies and elevated protein with lymphocytes in the cerebrospinal fluid. Disease severity was ranked on the Hughes functional scale; 17 patients were grade 4 or greater. The treatment responses to corticosteroid and intravenous methylprednisolone were favorable. Intravenous immunoglobulin was also used in combination with steroids. Seven patients died, including 4 who on mechanical ventilation.ConclusionPolyradiculoneuropathy induced by ICIs has a distinct subset of neurological irAEs and requires early recognition.
登录
查看更多内容
影响因子:
3.2
作者:
A. Kyriazoglou;M. Liontos;C. Papadopoulos;Afroditi Bilali;E. Kostouros;S. Pagoni;K. Doumas;M. Dimopoulos;A. Bamias
通讯作者:
A. Bamias
影响因子:
1.4
作者:
Akshita S Patel;R. Snook;A. Sehdev
通讯作者:
A. Sehdev
DOI:
--
发表时间:
1997
期刊:
影响因子:
--
作者:
R. Hughes;A. Swan;Cornblath;H. Hartung;Bril;T. Feasby;A. Hahn;A. Ropper;A. Steck;K. Toyka;J. Vallat;A. Asbury;J. Newsom;S. Button;R. Hohlfield;R. Voltz;B. Lecky;J. Winer;J. Rees;M. Donaghy;I. Dehaene;M. Marchau;M. Zandijcke;M. D’hooghe;W. Hacke;P. Newman;R. Shakir;P. Tilley;B. Khatri;J. Kumar;S. Sundrani;H. Willison;H. Katifi;C. Wiles;G. Hamann;S. Merkelbach;J. Stewart;L. Sales;M. Alves;I. Conceição;I. Pye;W. Robberecht;E. Peeters;J. Aasly;P. Fuhr;A. Tichelli;C. Sindic;P. Vandenbergh;F. Franck;D. Dive;G. Cavaletti;P. Santoro;T. Feasby;D. Miller;R. Howard;J. O'riordan;C. Chalk;T. Ben;J. Goldstein;M. Orshoven;J. Caekebeke;E. Schmedding;I. Ferguson;G. Stoll;R. Will;J. Pollard
通讯作者:
J. Pollard
影响因子:
10.9
作者:
Cafuir L;Lawson D;Desai N;Kesner V;Voloschin A
通讯作者:
Voloschin A
影响因子:
9.9
作者:
Dubey, Divyanshu;David, William S.;Guidon, Amanda C.
通讯作者:
Guidon, Amanda C.